Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection
- PMID: 9204295
- PMCID: PMC2627624
- DOI: 10.3201/eid0302.970207
Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection
Abstract
Rhodococcus equi and Arcanobacterium haemolyticum, formerly classified in the genus Corynebacterium, are members of the loosely defined taxon "coryneform" bacteria. Although they are the etiologic agents of distinct human infections, both organisms are frequently overlooked, which results in missed or delayed diagnoses. R. equi, long known as an important pathogen of immature horses, has become in the past three decades an opportunistic pathogen of severely immunosuppressed humans. Most cases are secondary to HIV infection. When specifically sought in throat swab cultures, A. haemolyticum is found responsible for 0.5% to 2.5% of bacterial pharyngitis, especially among adolescents. These two microorganisms represent a spectrum of disease in humans: from a mild, common illness to a rare life-threatening infection. Each organism elaborates lipid hydrolyzing enzymes (cholesterol oxidase by R. equi and sphingomyelinase D by A. haemolyticum) that are toxic to animals and humans and damaging to mammalian cell membranes. The participation of the cytotoxins in pathogenicity is discussed. Greater awareness of the properties of these two bacteria may promote faster, more accurate diagnoses and better clinical management.
Similar articles
-
[A diagnostic medium for Arcanobacterium haemolyticum and other bacterial species reacting with hemolytic synergism to the equi-factor of Rhodococcus equi].Epidemiol Mikrobiol Imunol. 2000 Aug;49(3):123-9. Epidemiol Mikrobiol Imunol. 2000. PMID: 11040494 Czech.
-
[A frequently overlooked bacteria in clinical microbiology laboratories: Arcanobacterium haemolyticum].Mikrobiyol Bul. 2011 Jul;45(3):535-40. Mikrobiyol Bul. 2011. PMID: 21935787 Turkish.
-
Rhodococcus equi: an emerging opportunistic pathogen.Trends Microbiol. 1996 Jan;4(1):29-33. doi: 10.1016/0966-842x(96)81502-2. Trends Microbiol. 1996. PMID: 8824792 Review.
-
Arcanobacterium haemolyticum pharyngitis and exanthem. Three case reports and literature review.Arch Dermatol. 1996 Jan;132(1):61-4. Arch Dermatol. 1996. PMID: 8546485
-
Molecular and infection biology of the horse pathogen Rhodococcus equi.FEMS Microbiol Rev. 2009 Sep;33(5):870-91. doi: 10.1111/j.1574-6976.2009.00181.x. Epub 2009 Apr 23. FEMS Microbiol Rev. 2009. PMID: 19453748 Review.
Cited by
-
Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis of sphingomyelin.Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6448-53. doi: 10.1073/pnas.0701354104. Epub 2007 Mar 30. Proc Natl Acad Sci U S A. 2007. PMID: 17400751 Free PMC article.
-
Phenotypic and genotypic characterization of Arcanobacterium haemolyticum isolates from infections of horses.J Clin Microbiol. 2009 Jan;47(1):124-8. doi: 10.1128/JCM.01933-08. Epub 2008 Nov 19. J Clin Microbiol. 2009. PMID: 19020059 Free PMC article.
-
Arcanolysin is a cholesterol-dependent cytolysin of the human pathogen Arcanobacterium haemolyticum.BMC Microbiol. 2011 Oct 26;11:239. doi: 10.1186/1471-2180-11-239. BMC Microbiol. 2011. PMID: 22029628 Free PMC article.
-
Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes.Microbiology (Reading). 2010 Jun;156(Pt 6):1836-1847. doi: 10.1099/mic.0.035915-0. Epub 2010 Mar 18. Microbiology (Reading). 2010. PMID: 20299405 Free PMC article.
-
Arcanobacterium haemolyticum Phospholipase D Enzymatic Activity Promotes the Hemolytic Activity of the Cholesterol-Dependent Cytolysin Arcanolysin.Toxins (Basel). 2018 May 23;10(6):213. doi: 10.3390/toxins10060213. Toxins (Basel). 2018. PMID: 29882842 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous